GlycoEra

BiotechnologySeries BZurich, Switzerlandglycoera.com

Latest round

Series B

Last raised

May 2025

Total raised

$179M

Investors

13

About GlycoEra

Founded in 2020 by Amir Faridmoayer, Dominique N. Sirena, and Veronica Gambillara Fonck, and based in Zürich, Switzerland operates a glycoengineering platform to develop a pipeline of biologics for the treatment of autoimmune and other diseases. GlycoEra specializes in precision immunology, focusing on biologics designed to selectively degrade disease-driving proteins, particularly autoantibodies in autoimmune disorders. The platform uses a novel approach to target and degrade specific extracellular proteins, enabling early intervention with potentially improved safety and effectiveness compared to broad-spectrum therapies. GlycoEra’s technology aims to enhance patient outcomes by providing targeted treatments for various diseases, including autoimmune conditions, with applications also in oncology, neurology, and infectious diseases.

Who invested in GlycoEra

13 investors across 3 rounds

See all investors in GlycoEra

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    May 17, 2025

    Amount

    $130M

    Investors

    Locked

  2. Series A

    Jan 5, 2024

    Amount

    Undisclosed

    Investors

    Locked

  3. Series A

    Nov 4, 2021

    Amount

    $49M

    Investors

    Locked

Questions about GlycoEra

Who invested in GlycoEra?

GlycoEra has 13 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has GlycoEra raised?

GlycoEra has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did GlycoEra last raise money?

GlycoEra's most recent round on record is a Series B, in May 2025.

What does GlycoEra do?

Founded in 2020 by Amir Faridmoayer, Dominique N.

Where is GlycoEra headquartered?

GlycoEra is headquartered in Zurich, Switzerland.

Which VCs invest in companies like GlycoEra?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at GlycoEra's stage. Their profiles are linked below.

Raising like GlycoEra? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.